Logo
  • About
    • What We Do
    • Team
    • Partners
  • Pipeline
  • Technologies
    • FastPharming®
    • Glycaneering™
    • LicKM
    • VLP
  • Resources
    • News
    • Events
    • Articles
    • Publications
  • Careers
  • Investors
  • Contact
  • Therapeutics
    • Fibrosis
      • IBIO-100
  • Vaccines
    • Covid-19
      • IBIO-201 Subunit Vaccine
    • Classic Swine Fever
      • IBIO-400
  • Research & Bioprocess
  • CDMO Services
    • Process Development
    • cGMP Manufacturing
    • Aseptic Fill/Finish
    • Bioanalytics
    • Factory Solutions
Investors

Press Releases

Investors

Investors

  • Overview
  • Company Info
    • Profile
    • Management Team
    • Presentations
  • News & Events
    • Press Releases
    • IR Calendar
  • Stock Data
    • Quote
    • Historical Data
  • SEC Filings
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • IR Contact
    • Email Alerts
    • Investor FAQ
  • News & Events

  • Press Releases
  • IR Calendar
Jun 03, 2019 8:00am EDT

iBio Launches New Sterile Fill-Finish Services

Apr 01, 2019 8:30am EDT

iBio Announces Appointment of Thomas F. Isett to Board of Directors

Dec 14, 2018 8:00am EST

iBio Provides Status Update on its Continuing Litigation Against Fraunhofer

Dec 03, 2018 8:00am EST

iBio to Present at Brazilian Ministry of Health’s Plant-Made Pharmaceutical Meeting

Oct 02, 2018 8:00am EDT

iBio and CC-Pharming Hold First Design and Strategy Meeting

Aug 22, 2018 4:10pm EDT

iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance

Jul 09, 2018 8:00am EDT

iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China

Jun 26, 2018 6:59pm EDT

iBio, Inc. Closes $16,000,000 Public Offering

Jun 22, 2018 7:26am EDT

iBio, Inc. Prices $16,000,000 Public Offering

Jun 08, 2018 4:30pm EDT

iBio, Inc. Announces Completion of 1-For-10 Reverse Stock Split

  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Footer Logo
  • Therapeutics
    • Fibrosis
      • IBIO-100
  • Vaccines
    • Covid-19
      • IBIO-201 Subunit Vaccine
    • Classic Swine Fever
      • IBIO-400
  • Research & Bioprocess
  • CDMO Services
    • Process Development
    • cGMP Manufacturing
    • Aseptic Fill/Finish
    • Bioanalytics
    • Factory Solutions

iBio, Inc.
iBio CDMO, LLC

8800 HSC Pkwy
Bryan, TX 77807

(979) 446-0027
LinkedIn
info@ibioinc.com
RSS News Feed

© 2021 iBio. All Rights Reserved.
Privacy Policy

  • About
  • Pipeline
  • Technologies
  • Resources
  • Careers
  • Investors
  • Contact